Nyxoah S.A. (EBR: NYXH)
Belgium
· Delayed Price · Currency is EUR 10.40
0.00 (0.00%)
Jan 20, 2025, 5:35 PM CET
Nyxoah Revenue
Nyxoah had revenue of 1.27M EUR in the quarter ending September 30, 2024, with 29.71% growth. This brings the company's revenue in the last twelve months to 5.08M, up 32.65% year-over-year. In the year 2023, Nyxoah had annual revenue of 4.35M with 40.99% growth.
Revenue (ttm)
5.08M
Revenue Growth
+32.65%
P/S Ratio
62.67
Revenue / Employee
34.57K
Employees
147
Market Cap
388.85M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 1.71B |
| UCB SA | 5.45B |
| Fagron NV | 820.76M |
| Ion Beam Applications | 465.75M |
| Onward Medical | -188.00K |
| Hyloris Pharmaceuticals | 6.94M |
| Sequana Medical NV | 433.50K |
| Biocartis Group NV | 60.82M |